Immediate Impact
25 standout
Citing Papers
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
The current landscape of the antimicrobial peptide melittin and its therapeutic potential
2024 Standout
Works of Peter Kopač being referenced
Immunological and clinical factors associated with adverse systemic reactions during the build‐up phase of honeybee venom immunotherapy
2015
Omalizumab in chronic urticaria: our experience and literature review
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Kopač | 435 | 140 | 188 | 215 | 33 | 593 | |
| Julie Leysen | 382 | 159 | 329 | 230 | 29 | 665 | |
| S. Erdmann | 353 | 145 | 211 | 400 | 39 | 680 | |
| Pilar García-Ortega | 278 | 64 | 146 | 181 | 36 | 535 | |
| T Lobera | 231 | 62 | 323 | 187 | 29 | 542 | |
| Arantza Vega | 564 | 368 | 144 | 124 | 28 | 737 | |
| Lichtenstein Lm | 350 | 230 | 111 | 79 | 27 | 652 | |
| Gabriele Cortellini | 277 | 41 | 384 | 145 | 30 | 680 | |
| Ricardo Madrigal‐Burgaleta | 132 | 101 | 482 | 176 | 27 | 588 | |
| A.L. de Weck | 225 | 166 | 85 | 89 | 38 | 517 | |
| M. J. Goikoetxea | 441 | 98 | 146 | 220 | 45 | 688 |
All Works
Login with ORCID to disown or claim papers
Loading papers...